Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024)
Nektar Therapeutics (NKTR) posted quarterly Change in Inventory of -$1.3 million for Q4 2024, down 21.85% year-over-year from -$1.7 million in Q1 2024, and down 960.98% quarter-over-quarter from -$123000.0 in Q3 2024.
Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024) Analysis & Trends
Nektar Therapeutics' Change in Inventory history runs 15 years deep, the most recent figure standing at -$1.3 million for Q4 2024.
- In Q4 2024, Change in Inventory fell 21.85% year-over-year to -$1.3 million; the TTM figure through Sep 2025 stood at -$1.3 million (down 396.2% YoY), while the FY2024 annual figure was -$497000.0, up 28.9% from the prior year.
- Change in Inventory for Q4 2024 stood at -$1.3 million, down from -$123000.0 in the prior quarter.
- The five-year high for Change in Inventory was $2.4 million in Q4 2020, with the low at -$2.4 million in Q3 2023.
- The 5-year median for Change in Inventory is $389500.0 (2020), against an average of $267050.0.
- Peak annual rise in Change in Inventory reached 570.38% in 2023, while the deepest fall reached 838.62% in 2023.
- Nektar Therapeutics' Change in Inventory stood at $2.4 million in 2020, then sank by 80.38% to $471000.0 in 2021, then tumbled by 69.21% to $145000.0 in 2022, then slumped by 838.62% to -$1.1 million in 2023, then decreased by 21.85% to -$1.3 million in 2024.
- Business Quant data shows NKTR's Change in Inventory at -$1.3 million in Q4 2024, -$123000.0 in Q3 2024, and -$212000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.31 Mn |
| Dec 31, 2024 | -1.31 Mn |
| Sep 30, 2024 | -123,000.00 |
| Sep 30, 2024 | -123,000.00 |
| Jun 30, 2024 | -212,000.00 |
| Jun 30, 2024 | -212,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | -1.07 Mn |
| Dec 31, 2023 | -1.07 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Jun 30, 2023 | 754,000.00 |
| Jun 30, 2023 | 754,000.00 |
| Mar 31, 2023 | 1.99 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 145,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 2.09 Mn |
| Sep 30, 2022 | 2.09 Mn |